Belgium Contraceptive Devices Market Report 2022 to 2030

Belgium Contraceptive Devices Market Analysis

$ 3999

Belgium's Contraceptive Devices Market is expected to witness growth from $28 Mn in 2022 to $53 Mn in 2030 with a CAGR of 8.00% for the forecasted year 2022-30. The population of Belgium is increasing, and the proportion of urban dwellers is rising. Due to the increased accessibility of healthcare and family planning services for residents in metropolitan areas, there is an increase in the need for contraceptives. The change in sexual behavior brought about by Belgium's modern lifestyle is driving the demand for contraceptives. The market is segmented by type and by gender. Some key players in this market include Merck Sharp & Dohme, Organon Heist, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.

ID: IN10BEMD005 CATEGORY: Medical Devices GEOGRAPHY: Belgium AUTHOR: Jigyasu Bhandari

Buy Now

Belgium Contraceptive Devices Healthcare Market Executive Analysis

Belgium's Contraceptive Devices Market size is at around $28 Mn in 2022 and is projected to reach $53 Mn in 2030, exhibiting a CAGR of 8.00% during the forecast period. In Belgium, the administration and upkeep of the public healthcare system will receive 0.8% of GDP in 2022. Overall health spending in Belgium as a percentage of GDP increased from 11.28% in 2018 to 13.2% in 2023. The overall spending is higher than the EU average. Over the past ten years, public spending has been continuously increasing and has typically kept up with levels in the European Union. (EU).

In Belgium, there were 62 maternal deaths per 100,000 live births in 2022. The prevalence of sexually transmitted infections is high in Belgium. In 2022, Belgium had an incidence rate of 625 chlamydia infections per 100,000 people, 328 gonorrhea cases per 100,000 people, and 3.8 syphilis cases per 100,000 people. Young persons between the ages of 17 to 29 were found to have the highest incidence of STIs. A contraceptive method is an essential tool for family planning and reproductive health. In Belgium, a sizable portion of the population uses contraceptive techniques that are readily available and accessible. Couples can plan their family size and spacing while avoiding unplanned pregnancies by using contraceptive techniques. This could be advantageous for a family's social and financial stability as well as the mother's and child's health. Since they can reduce the need for more expensive medical procedures like pregnancy and abortion, contraceptive methods can ultimately save money.

Belgium Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

The population of Belgium is increasing, and the proportion of urban dwellers is rising. Due to the increased accessibility of healthcare and family planning services for residents in metropolitan areas, there is an increase in the need for contraceptives. The change in sexual behaviour brought about by Belgium's modern lifestyle is driving the demand for contraceptives. People are postponing marriage and beginning babies, for instance, which results in extended periods of contraception use. Manufacturers are always coming out with novel contraceptive methods that are both more efficient and simpler to use. For instance, more recent contraceptives have become more popular because of their high degree of efficacy and ease, such as hormone patches, intrauterine devices (IUDs), and implants.

Market Restraints

In Belgium, some contraceptive methods could have negative side effects or health hazards, which might reduce their appeal to some users. This is especially true for hormonal contraceptives, which can result in negative side effects like headaches, weight gain, and altered moods. Access to healthcare services, particularly family planning services, may be restricted in some areas of Belgium. This may restrict some populations' access to the availability of contraception. There may still be a dearth of knowledge and education about the advantages of utilising contraceptives despite the increased trend towards family planning and contraception. This may reduce consumer demand for certain goods and make it challenging for producers to find new clients.

Competitive Landscape

Key Players

Merck Sharp & Dohme (BE)
Organon Heist (BE)
Mylan Laboratories
CooperSurgical
Pfizer
Teva Pharmaceutical

Healthcare Policies and Regulatory Landscape

The Medical Devices Regulation (MDR), which outlines the standards for the safety, effectiveness, and quality of medical devices, including contraceptives, governs the regulatory environment for contraceptive devices in Belgium. Additionally, the nation's medical equipment, including contraceptive devices, is governed by the Belgian Federal Agency for Medicines and Health Products (FAMHP). The Belgian government has made many actions to support family planning and contraception in terms of healthcare policies. Contraceptives, for instance, are subsidised by the government, making them more accessible and inexpensive to a greater population. In order to raise public understanding of the advantages of family planning and contraception, the government also sponsors educational initiatives.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.